Circulating Level of Monocyte Chemoattractant Protein-1 and Risk of Coronary Artery Disease: A Case–Control and Mendelian Randomization Study

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256. doi:10.21037/atm.2016.06.33
   PubMed Web of Science ®Google Scholar
• Collaborators GBDCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–1788.
   Web of Science ®Google Scholar
• Okami Y, Ueshima H, Nakamura Y, et al.; Group NDR. Risk factors that most accurately predict coronary artery disease based on the duration of follow-up- NIPPON DATA80. Circ J. 2020. doi:10.1253/circj.CJ-20-0739
   Web of Science ®Google Scholar
• Harrington RA. Targeting inflammation in coronary artery disease. N Engl J Med. 2017;377(12):1197–1198. doi:10.1056/NEJMe1709904
   Web of Science ®Google Scholar
• Lim SB, Di Lee W, Vasudevan J, Lim WT, Lim CT. Liquid biopsy: one cell at a time. NPJ Precis Oncol. 2019;3:23. doi:10.1038/s41698-019-0095-0
   Web of Science ®Google Scholar
• Georgakis MK, Gill D, Rannikmae K, et al. Genetically determined levels of circulating cytokines and risk of stroke. Circulation. 2019;139(2):256–268. doi:10.1161/CIRCULATIONAHA.118.035905
   PubMed Web of Science ®Google Scholar
• Abozaid MA, Ahmed GH, Tawfik NM, Sayed SK, Ghandour AM, Madkour RA. Serum and urine monocyte chemoattractant protein-1 as a markers for lupus nephritis. Egypt J Immunol. 2020;27(1):97–107.
   Google Scholar
• Huang HH, Chen LY, Chen KY, Lee YC, Tsai CY, Chen CY. Increased monocyte chemoattractant protein-1 and nitrotyrosine are associated with increased body weight in patients with rheumatoid arthritis after etanercept therapy. Neuropeptides. 2020;84:102100. doi:10.1016/j.npep.2020.102100
   Web of Science ®Google Scholar
• Li S, Xu Y, Zhang Y, et al. Mendelian randomization analyses of genetically predicted circulating levels of cytokines with risk of breast cancer. NPJ Precis Oncol. 2020;4:25. doi:10.1038/s41698-020-00131-6
   Web of Science ®Google Scholar
• Georgakis MK, Malik R, Bjorkbacka H, et al. Circulating monocyte chemoattractant protein-1 and risk of stroke: meta-analysis of population-based studies involving 17 180 individuals. Circ Res. 2019;125(8):773–782. doi:10.1161/CIRCRESAHA.119.315380
   Web of Science ®Google Scholar
• Bin lim S, Chua MLK, Yeong JPS, Tan SJ, Lim WT, Lim CT. Pan-cancer analysis connects tumor matrisome to immune response. NPJ Precis Oncol. 2019;3:15. doi:10.1038/s41698-019-0087-0
   PubMed Web of Science ®Google Scholar
• Georgakis MK, de Lemos JA, Ayers C, et al. Association of circulating monocyte chemoattractant protein-1 levels with cardiovascular mortality: a meta-analysis of population-based studies. JAMA Cardiol. 2020. doi:10.1001/jamacardio.2020.5392
   Web of Science ®Google Scholar
• Hoogeveen RC, Morrison A, Boerwinkle E, et al. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: atherosclerosis risk in communities study. Atherosclerosis. 2005;183(2):301–307. doi:10.1016/j.atherosclerosis.2005.03.007
   Web of Science ®Google Scholar
• Kidd LR, Jones DZ, Rogers EN, et al. Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study. Hered Cancer Clin Pract. 2012;10(1):16. doi:10.1186/1897-4287-10-16
   PubMed Web of Science ®Google Scholar
• van Wijk DF, van Leuven SI, Sandhu MS, et al. Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 2010;30(7):1460–1466. doi:10.1161/ATVBAHA.110.205526
   Web of Science ®Google Scholar
• Canoui-Poitrine F, Luc G, Mallat Z, et al. Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology. 2011;77(12):1165–1173. doi:10.1212/WNL.0b013e31822dc7c8
   PubMed Web of Science ®Google Scholar
• Schiopu A, Bengtsson E, Goncalves I, Nilsson J, Fredrikson GN, Bjorkbacka H. Associations between macrophage colony-stimulating factor and monocyte chemotactic protein 1 in plasma and first-time coronary events: a nested case-control study. J Am Heart Assoc. 2016;5(9). doi:10.1161/JAHA.115.002851
   Web of Science ®Google Scholar
• Ahola-Olli AV, Wurtz P, Havulinna AS, et al. Genome-wide association study identifies 27 Loci influencing concentrations of circulating cytokines and growth factors. Am J Hum Genet. 2017;100(1):40–50. doi:10.1016/j.ajhg.2016.11.007
   PubMed Web of Science ®Google Scholar
• Deloukas P, Kanoni S, Willenborg C, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45(1):25–33. doi:10.1038/ng.2480
   PubMed Web of Science ®Google Scholar
• Ardigo D, Assimes TL, Fortmann SP, et al. Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics. 2007;31(3):402–409. doi:10.1152/physiolgenomics.00104.2007
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 1989;244(2):487–493. doi:10.1016/0014-5793(89)80590-3
   Web of Science ®Google Scholar
• Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest. 1991;88(4):1121–1127. doi:10.1172/JCI115411
   PubMed Web of Science ®Google Scholar
• Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, Graves DT. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A. 1992;89(12):5371–5375. doi:10.1073/pnas.89.12.5371
   Web of Science ®Google Scholar
• Koch AE, Kunkel SL, Harlow LA, et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest. 1992;90(3):772–779. doi:10.1172/JCI115950
   PubMed Web of Science ®Google Scholar
• Bonner ER, Bornhorst M, Packer RJ, Nazarian J. Liquid biopsy for pediatric central nervous system tumors. NPJ Precis Oncol. 2018;2:29. doi:10.1038/s41698-018-0072-z
   Web of Science ®Google Scholar
• Kim S, Han Y, Kim SI, Kim HS, Kim SJ, Song YS. Tumor evolution and chemoresistance in ovarian cancer. NPJ Precis Oncol. 2018;2:20. doi:10.1038/s41698-018-0063-0
   PubMed Web of Science ®Google Scholar
• Urrego-Callejas T, Alvarez SS, Arias LF, et al. Urinary levels of ceruloplasmin and monocyte chemoattractant protein-1 correlate with extra-capillary proliferation and chronic damage in patients with lupus nephritis. Clin Rheumatol. 2020. doi:10.1007/s10067-020-05454-0
   Web of Science ®Google Scholar
• Savelieva I, Camm AJ. A new biomarker in atrial fibrillation: monocyte chemoattractant protein-1-induced protein. Cardiology. 2019;144(3–4):122–124. doi:10.1159/000502253
   Web of Science ®Google Scholar
• Egashira K, Zhao Q, Kataoka C, et al. Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res. 2002;90(11):1167–1172. doi:10.1161/01.RES.0000020561.03244.7E
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Tian C, et al. The −2518A/G polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and diabetes risk: a meta-analysis. Diabetes Res Clin Pract. 2011;94(3):e89–92. doi:10.1016/j.diabres.2011.09.005
   Web of Science ®Google Scholar
• Li M, Chen Y, Zhang Y, Li D, Liu J. Correlation between monocyte chemoattractant protein-1/chemokine (C-C motif) ligand 2 and coronary plaque characteristics. Exp Biol Med. 2020;245(15):1335–1343. doi:10.1177/1535370220941424
   Web of Science ®Google Scholar